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ORIGINAL RESEARCH

Subclinical Atherosclerosis and Obesity Phenotypes Among Mexican
Americans
Susan T. Laing, MD, MSc; Beverly Smulevitz, BS; Kristina P. Vatcheva, MS; Mohammad H. Rahbar, PhD; Belinda Reininger, DrPH;
David D. McPherson, MD; Joseph B. McCormick, MD; Susan P. Fisher-Hoch, MD

Background-—Data on the inﬂuence of obesity on atherosclerosis in Hispanics are inconsistent, possibly related to varying
cardiometabolic risk among obese individuals. We aimed to determine the association of obesity and cardiometabolic risk with
subclinical atherosclerosis in Mexican-Americans.
Methods and Results-—Participants (n=503) were drawn from the Cameron County Hispanic Cohort. Metabolic health was deﬁned
as <2 of the following: blood pressure ≥130/85; triglyceride ≥150 mg/dL; high-density lipoprotein cholesterol <40 mg/dL (men)
or <50 mg/dL (women); fasting glucose ≥100 mg/dL; homeostasis model assessment of insulin resistance value >5.13; or highsensitivity C-reactive protein >3 mg/L. Carotid intima media thickness (cIMT) was measured. A high proportion of participants
(77.8%) were metabolically unhealthy; they were more likely to be male, older, with fewer years of education, and less likely to meet
daily recommendations regarding fruit and vegetable servings. One-third (31.8%) had abnormal carotid ultrasound ﬁndings. After
adjusting for covariates, mean cIMT varied across the obesity phenotypes (P=0.0001); there was no difference among the
metabolically unhealthy regardless of whether they were obese or not. In multivariable analysis, after adjusting for covariates,
cardiometabolic risk (P=0.0159), but not obesity (P=0.1446), was signiﬁcantly associated with subclinical atherosclerosis.
Conclusions-—In Mexican-Americans, cardiometabolic risk has a greater effect on early atherosclerosis development than body
mass index. Non-obese but metabolically unhealthy participants had similar development of subclinical atherosclerosis as their
obese counterparts. Interventions to maintain metabolic health among obese and non-obese patients may be a more important
goal than weight loss alone. ( J Am Heart Assoc. 2015;4:e001540 doi: 10.1161/JAHA.114.001540)
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O

besity has been increasing in epidemic proportions over
the past decades particularly in ethnic minority
groups.1,2 Recently, there have been reports that this obesity
trend may be levelling off in the United States,3 but that there
is a disturbing ethnic disparity with a slower decline in nonHispanic blacks and an increase in Mexican-Americans
compared with non-Hispanic whites.4 Obesity has an adverse
impact on most of the cardiovascular (CV) risk factors5 with a
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shift in the incidence of these risk factors to a younger age.6
Obesity is thought to affect CV events through adverse
remodeling of the large arteries, and a higher prevalence of
subclinical vascular disease has been shown among those
who are obese compared with those who are not.7,8 However,
the inﬂuence of obesity on CV mortality is not as clear, and
substantial data have been published over recent years
demonstrating better prognosis in some obese patients
compared with their leaner counterparts with the same CV
disease (CVD).9,10 This discrepancy may be related to varying
cardiometabolic proﬁles among obese individuals, which may
have a more important effect on cardiovascular risk than
obesity. Indeed the concept of “metabolically healthy” obesity
has been studied and several investigators have recently
shown that coronary heart disease may not be increased in
this obesity phenotype.11,12
Mexican-Americans have very high prevalence of obesity
compared with non-Hispanic whites. Data on CVD in MexicanAmericans are likewise conﬂicting and despite the very high
obesity prevalence, reported CV death rates are no higher
than in whites.13 With the changing landscape of ethnic
diversity in the United States, it is important to understand CV
Journal of the American Heart Association

1

Atherosclerosis and Obesity in Mexican Americans

Laing et al

Methods
Study Population
This study was approved by the Institutional Review Board of
the University of Texas Health Science Center-Houston and all
participants gave written informed consent. Study participants were a subset of the Cameron County Hispanic Cohort
(CCHC) (n=503), recruited from randomly selected blocks
according to the 2000 Census as described previously.14 The
CCHC is a homogenous community-dwelling Mexican-American cohort living in Brownsville (Cameron County), Texas, a
city on the lower Rio Grande River at the United StatesMexico border.
Extensive family, socioeconomic, educational, and personal
medical histories, as well as physical activity and dietary
histories, were obtained using a directed questionnaire.
Surveys and data collection were conducted in the participants’ language of preference (Spanish or English) by bilingual
research nurses and ﬁeld workers. Physical activity was
assessed using the International Physical Activity Questionnaire short-form (IPAQ);15 reported minutes of physical
activity per week were weighted by a metabolic equivalent
(MET; multiples of resting energy expenditure) resulting in a
physical activity estimate expressed as MET-minutes per
week.15 Participants were asked to fast for at least 10 hours
overnight before a visit to the Clinical Research Unit.
Anthropometric measurements obtained included height,
weight, and waist circumference. Waist circumference (visceral adiposity) was measured at the level of the umbilicus to
the nearest 0.2 cm, with the subject in a standing position
and breathing normally. Height was measured to the nearest
0.2 cm using a stadiometer. BMI was calculated as weight in
kilograms divided by height squared in meters (kg/m2). The
average of 3 blood pressure (BP) and HR readings taken
5 minutes apart were used. Laboratory studies performed
included fasting lipid panel, hemoglobin (Hb) A1c, fasting
plasma glucose, and fasting serum insulin. Homeostasis
model assessment insulin resistance index (HOMA-IR) was
calculated as fasting glucose (mg/dL)/189 fasting insulin
(mU/L)/22.5.16 High-sensitivity C-reactive protein (hsCRP)
levels were measured using a high-sensitivity immunoassay
(Dimension Vista 1500; Siemens Corporation, Washington,
DOI: 10.1161/JAHA.114.001540

DC). High-sensitivity CRP levels >10 mg/L were excluded
from analysis as such high levels likely represent acute
illness.17
The presence of hypertension was both self-reported and
measured as described below. The subject was deemed to
be hypertensive if the mean systolic blood pressure (SBP)
was ≥140 mm Hg or the mean diastolic blood pressure
(DBP) was ≥90 mm Hg.18 Classiﬁcation of diabetes was also
both self reported and based on measurement of HbA1c
(HbA1c>6.5%) as per the latest guidelines from the American
Diabetes Association.19 Smoking status was deﬁned as an
afﬁrmative answer to the question “Do you currently smoke
cigarettes?” BMI was categorized according to the National
Heart Lung and Blood Institute (NHLBI) with overweight
deﬁned as a BMI ≥25.0 kg/m2 and obesity deﬁned as a
BMI≥30.0 kg/m2. Morbid obesity was deﬁned as a BMI
≥40.0 kg/m2.20

Obesity Phenotypes
Participants were categorized as obese or non-obese using a
BMI cutoff of ≥30.0 kg/m2 and then were further categorized
as metabolically healthy or unhealthy. Metabolic health was
deﬁned as having <2 of the following cardiometabolic
abnormalities: SBP ≥130 mm Hg and/or DBP ≥85 mm Hg
or on antihypertensive medication; triglyceride ≥150 mg/dL;
high-density lipoprotein cholesterol <40 mg/dL in men or
<50 mg/dL in women; fasting glucose ≥100 mg/dL or on
hypoglycemic medication; HOMA-IR value >5.13; or hsCRP
>3 mg/L.21,22 Waist circumference was not included due to
its high correlation with BMI.23 To better assess the
inﬂammatory component of cardiometabolic risk, hsCRP
was added to our criteria of metabolic health, as has been
suggested by other investigators.21,22,24

Carotid Ultrasound Evaluation of Subclinical
Atherosclerosis
Carotid ultrasound studies to evaluate subclinical atherosclerosis were performed using the Siemens Acuson X300
ultrasound system (Malvern, PA) using a VF 13-5 linear array
transducer. The protocol was designed following guidelines
from the American Society of Echocardiography consensus
statement on subclinical vascular disease.25 Both common
carotids were imaged from 3 different angles for a total of 6
images. Carotid plaque presence was determined by examining the carotid bulb, its bifurcation and the carotid branch
arteries in addition to the common carotid artery. Carotid IMT
was measured using the Carotid Analyzer software (Medical
Imaging Applications, Coralville, IA), a semi-automated border
detection program. Measurements were made at the R-wave
of the electrocardiogram on a minimum of 2 clips from each
Journal of the American Heart Association
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risk in distinct racial cohorts. We hypothesize that cardiometabolic risk has a greater effect on early atherosclerosis
development than obesity in Mexican-Americans and that the
inﬂuence of cardiometabolic risk is more important than body
mass index (BMI) alone. This study aimed to determine the
association of subclinical atherosclerosis to obesity and
abnormal cardiometabolic proﬁle in asymptomatic, community-dwelling, Mexican-Americans.
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Statistical Analysis
All analyses reported in this paper are adjusted for age and
gender using the sampling weights. In addition, the analyses
have taken into consideration clustering effects of multiple
participants from the same household as well as census
block.14 Data are summarized as weighted mean and
standard error for continuous variables and weighted
frequency and percentages for categorical variables. Participant demographics were stratiﬁed by gender and evaluated
using univariable analysis. Cohort demographics and metabolic characteristics were compared by obesity phenotype
groups and evaluated using univariable and multivariable
analyses. Speciﬁcally, for comparing continuous variables,
we applied survey-weighted linear regression models from
which Tukey-Kramer-adjusted P values were calculated and
used for multiple pairwise mean comparisons. For comparing
categorical variables, we applied survey-weighted logistic
regression to obtain the Rao-Scott F-adjusted chi-square P
values. Contingency coefﬁcient was used to measure the
degree of relationship between abnormal carotid ultrasound
and obesity phenotypes. Multivariable survey-weighted
logistic regression analysis was performed to obtain the
weighted odds ratios (OR) and 95% conﬁdence intervals (CI)
for abnormal carotid ultrasound by the obesity phenotype
groups. Initially, a multivariable survey-weighted linear
regression model was created to identify factors associated
with mean cIMT, among variables including the obesity
phenotypes, age, gender, SBP, diabetes status, lipids, CRP,
reported minutes of physical activity per week, servings
of fruits and vegetables per day, and smoking status.
Further analysis using a multivariable weighted linear
regression model was then performed to assess the effects
of cardiometabolic risk and obesity on mean cIMT, after
adjusting for signiﬁcant confounders. Variables that were not
signiﬁcant and were not confounders were excluded from
the ﬁnal model. Two-way additive scale interaction effects
between each pair of independent variables were tested. All
statistical tests were two sided and conducted at 5% level of
signiﬁcance, and all analyses were performed using SAS 9.2
(SAS Institute Inc., Cary, NC).
DOI: 10.1161/JAHA.114.001540

Results
Demographics and metabolic characteristics are listed in
Table 1. This is a relatively young cohort with a mean age of
50.40.95 years (range 18 to 85 years); 41% (n=159) were
male. There was a high prevalence of CV risk factors in this
cohort; 39% were hypertensive, 20.1% had diabetes, and
56.5% had dyslipidemia, with no gender differences in
prevalence. However, men were more likely to be smokers
than women (18.1% versus 6.7%, P<0.001). More than half of
the cohort participants were obese (52.5%) and there were
also no signiﬁcant gender differences for the prevalence of
obesity in the cohort. The mean CRP was 3.50.2 mg/L,
which is considered to be in the high-risk category for
cardiovascular events,17 and there was no difference in CRP
levels between men and women. Only 32.2% of the cohort
met the minimum recommendations of ≥600 MET-minutes of
physical activity per week,26,27 and even less (12.5%) met the
American Heart Association (AHA) recommendations for
servings of fruit and vegetables per day,28 with no gender
differences for both variables. The mean duration of education
was 10.24.1 years. The median annual income was
$20 000. Only 43.4% of women were employed versus
73.7% of the men (P<0.0001). Among those women who were
employed, median annual income was signiﬁcantly lower in
women compared with men (P=0.0008).
There was a high proportion (77.8%) of participants who
were classiﬁed as metabolically unhealthy (n=149 [29.7%] for
non-obese participants and n=250 [48.1%] for obese participants; Table 1). Compared with those who were metabolically
healthy, those classiﬁed as metabolically unhealthy were
more likely to be male (44.4% versus 29.2%, P=0.029), were
older (51.40.9 years versus 46.32.3 years, P=0.0325),
had larger waist circumference (106.91.14 cm versus
93.81.1 cm, P<0.0001), and had fewer years of education
(10.30.3 years versus 12.10.5 years, P=0.0017). They
were also less likely to meet the recommended guidelines for
eating 5 or more servings of fruits and vegetables per day
(8.6% versus 24.4%, P<0.0046) compared with those who
were metabolically healthy.
Nearly one-third of the cohort (29.7%) was classiﬁed as
metabolically unhealthy non-obese. Among the non-obese
participants, those who were classiﬁed as metabolically
unhealthy were also more likely to be male (48.8% versus
29.1%, P=0.026), were older (53.21.4 years versus
46.72.7 years, P=0.028), had larger waist circumference
(96.50.8 cm versus 91.11.0 cm, P<0.0001), and had fewer
years of education (10.00.4 years versus 12.20.6 years,
P=0.003) compared with the metabolically healthy. They were
also less likely to meet the recommended servings of fruits and
vegetables per day (6.8% for unhealthy non-obese versus 21.5%
for healthy non-obese, P=0.019). In this cohort, among the
Journal of the American Heart Association
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side and the results were averaged. Mean cIMT was
categorized as being either <or ≥75th percentile for age
and gender.25 Carotid plaque was deﬁned as an area of wall
thickening that was >50% of the thickness of the surrounding
wall. Abnormal carotid ultrasound was then deﬁned as a cIMT
≥75% for age and gender and/or presence of atherosclerotic
plaque. All measurements were performed by a single blinded
expert reader. Replicate readings were performed on 5% of
the cohort and the intraclass correlation coefﬁcient for our
laboratory was 0.96.
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Table 1. Cohort Demographics and Metabolic Characteristics
Metabolically Healthy

Metabolically Unhealthy

Total

Healthy Non-Obese

Healthy Obese

Unhealthy Non-Obese

Unhealthy Obese

n=503

n=79 (17.8%)

n=25 (4.4%)

n=149 (29.7%)

n=250 (48.1%)

P Value

Men

159 (41.0)

24 (29.1)

6 (29.7)

59 (48.8)

70 (41.7)

0.1063

Employed

261 (55.8)

52 (63.8)

19 (74.5)

72 (50.3)

118 (54.6)

0.2147

Met minimum recommendations
for physical activity of ≥600
MET-minutes/week

123 (32.2)

29 (44.7)

8 (35.4)

41 (37.2)

45 (23.9)

0.0625

Met recommendations
of ≥5 servings of fruit and
vegetables per day

45 (12.5)

11 (21.5)

6 (37.4)

10 (6.8)

18 (9.6)

0.0071

Categorical variables, n (%)

Current smokers

41 (11.3)

8 (10.3)

1 (2.5)

11 (11.7)

21 (12.2)

0.4845

Diabetes (ADA2010_DM variable)

108 (20.1)

0 (0)

0 (0)

32 (20.1)

76 (29.2)

0.1188

CRP≥3 mg/L

335 (71.3)

28 (50.4)

10 (52.4)

93 (64.5)

204 (85.1)

<0.0001

Continuous variables, meanSE
Age, y

50.30.9

46.72.7

44.83.4

53.21.4

50.31.2

0.0421

Annual household
income (US dollars)

354253664.2

4355612153.0

319215571.5

299054978.3

354514270.5

0.6791

Years of education

10.70.3

12.20.6

11.90.9

10.00.4

10.60.4

0.0134

Total minutes of
moderate and vigorous
activity

901.2179.6

1212.7295.4

4148.03481.4

806.3148.0

519.3114.8

0.075

Total cholesterol, mg/dL

182.72.3

184.06.5

187.68.1

181.34.0

182.63.1

0.8471

Triglycerides, mg/dL

153.45.6

86.15.6

89.76.9

172.011.0

172.77.4

<0.0001

HDL-cholesterol, mg/dL

44.80.9

55.31.5

54.02.9

42.92.3

41.20.9

<0.0001

LDL-cholesterol, mg/dL

107.91.9

112.15

114.85.8

105.03.4

107.62.8

0.4184

BMI, kg/m2

31.30.4

25.90.3

33.20.6

26.80.2

35.80.6

<0.0001

Waist circumference, cm

104.01.0

91.11.0

104.91.8

96.50.8

113.31.4

<0.0001

Systolic blood pressure, mm Hg

118.10.9

109.91.5

108.82.4

119.91.7

120.91.4

<0.0001

Diastolic blood pressure, mm Hg

72.30.6

67.01.4

69.01.6

72.40.9

74.50.9

0.0007

CRP, mg/L*

3.50.2

2.40.4

3.50.3

2.10.4

4.30.3

<0.0001

Insulin, mg/dL

15.31.1

8.30.6

11.50.9

14.22.0

19.21.8

<0.0001

Fasting blood glucose, mg/dL

107.21.9

91.30.9

95.61.9

108.53.8

113.32.7

<0.0001

HOMA IR

4.00.3

1.80.1

2.70.2

3.60.4

5.30.5

<0.0001

Hba1c, %

5.60.1

5.10.1

5.20.2

5.60.1

5.90.1

<0.0001

Data are adjusted for the probability of sampling using weights taking into consideration clustering effects arising from the same census block and household. BMI indicates body mass
index; CRP, C-reactive protein; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment insulin resistance index; LDL, low-density lipoprotein; MAT, metabolic equivalent.
*CRP>10 mg/L excluded, n=283.

obese participants, only 4.4% (n=25) were classiﬁed as
metabolically healthy. In contrast to the non-obese participants,
age and gender were not different among the metabolically
healthy or unhealthy obese. Obese metabolically unhealthy
participants had similarly larger waist circumference
(113.31.4 cm versus 105.01.8 cm, P=0.0002) and were
less likely to meet the recommended servings of fruits and
DOI: 10.1161/JAHA.114.001540

vegetables per day (9.6% for unhealthy obese versus 37.4% for
healthy obese, P=0.0065). In contrast to the non-obese
participants however, hsCRP levels were different between
the metabolically healthy and unhealthy obese participants with
the metabolically unhealthy obese more likely to have elevated
hsCRP levels (≥3 mg/L) than their metabolically healthy
counterparts (85.1% versus 52.4%, P=0.0009).
Journal of the American Heart Association
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Table 2. Carotid Ultrasound Findings
Metabolically Healthy

Metabolically Unhealthy

Total

Healthy Non-Obese

Healthy Obese

Unhealthy Non-Obese

Unhealthy Obese

n=503

n=79

n=25

n=149

n=250

P Value

Mean cIMT ≥75%

85 (17.5)

2 (1.47)

3 (8.77)

29 (21.6)

51 (21.71)

0.0005

Presence of plaque

115 (24.2)

10 (15.27)

4 (16.69)

36 (24.34)

65 (28.11)

0.2502

Abnormal carotid study

156 (31.8)

11 (15.59)

6 (22.72)

50 (33.79)

89 (37.4)

0.0241

0.670.01

0.600.02

0.610.02

0.680.02

0.680.02

0.0001

Categorical variables, n (%)

Continuous variables, meanSE
Mean cIMT, mm

cIMT indicates carotid intima media thickness.

The mean cIMT for the cohort was 0.670.01 mm, with
men having thicker mean cIMT than women (0.690.02 mm
in men versus 0.650.01 mm in women; P=0.0228; Table 2).
Age was highly correlated with cIMT (r=0.59, P<0.0001).
One-third of the cohort (31.8%) had abnormal carotid
ultrasound ﬁndings deﬁned as a cIMT ≥75% for age and
gender and/or presence of atherosclerotic plaque. Mean cIMT
varied across the 4 obesity phenotypes (P=0.0001). There
was no difference in mean cIMT between the obese and non-

obese metabolically healthy phenotypes (P=0.986). Similarly,
there was no difference in mean cIMT among those who were
classiﬁed as metabolically unhealthy regardless of whether
they were obese or not (P=1.00). In contrast, there was a
signiﬁcant difference in mean cIMT between the obese
metabolically healthy and unhealthy phenotypes (P=0.038)
and the non-obese metabolically healthy and unhealthy
phenotypes (P=0.0024, Figure). The weighted odds ratio for
having an abnormal carotid ultrasound study was signiﬁcantly

Figure. Obesity phenotypes and mean carotid intima media thickness.
DOI: 10.1161/JAHA.114.001540
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Table 3. Abnormal Carotid Ultrasound Study and Obesity Phenotype
Metabolically Healthy

Abnormal carotid ultrasound

Metabolically Unhealthy

Healthy Non-Obese

Healthy Obese

Unhealthy Non-Obese

Unhealthy Obese

n=79

n=25

n=149

n=250

P Value

n (%)*

n (%)*

n (%)*

n (%)*

F approximation of Rao–Scott
design-adjusted chi-square
test P-value
0.0241

Yes

11 (15.6)

6 (22.7)

50 (33.8)

89 (37.4)

No

68 (84.4)

19 (77.3)

99 (66.2)

161 (62.6)

Weighted OR for abnormal carotid
ultrasound (95% CI)

Reference

1.6 (0.42, 5.97)

2.8 (1.10, 6.93)

3.26 (1.30, 8.03)

Wald chi-square test for parameter
estimates P-values

Reference

0.4907

0.0302

0.0114

Overall: 0.0549

*Unweighted frequencies and weighted percentages.

greater than one only for the metabolically unhealthy
phenotypes regardless of whether they were obese or nonobese [OR=2.8 (95% CI 1.10, 6.93), P=0.0302 for the nonobese participants; OR=3.26 (95% CI 1.30, 8.03), P=0.0114
for the obese participants, but was not signiﬁcantly greater
than one for the metabolically healthy obese phenotype
(OR=1.6 [95% CI 0.42, 5.97], P=0.4907, Table 3).
Among the criteria used to describe metabolic health,
systolic and diastolic BP, mean fasting glucose, and HOMA-IR
remained signiﬁcantly correlated with obesity phenotype and
mean cIMT after adjusting for age and gender. Our ﬁndings
from a multivariable survey weighted linear regression model
(which included the obesity phenotypes, age, gender, SBP,
diabetes status, lipids, CRP, servings of fruit and vegetables
per day, physical activity, and smoking status), revealed that
age (P<0.0001), gender (P=0.0039), obesity phenotypes
(P=0.0275), SBP (P=0.0179), and diabetes (P=0.0381)
remained signiﬁcantly associated with mean cIMT. In further
analysis, using a multivariable analysis model, when we
included obesity and cardiometabolic risk (which takes into
account SBP and diabetes) as separate variables, we found
that cardiometabolic risk (P=0.0159), but not obesity
(P=0.1446), was signiﬁcantly associated with subclinical
atherosclerosis even after adjusting for age and gender
(Table 4). Metabolically healthy participants had lower mean
cIMT (0.640.01 versus 0.680.01 for metabolically
unhealthy, P=0.0159, Table 4) regardless of whether they
were obese or not. We did not ﬁnd any signiﬁcant interaction
effects among the covariates.

Discussion
In Mexican-Americans, cardiometabolic risk has a greater
effect on early atherosclerosis development than BMI alone,
and non-obese but metabolically unhealthy participants had
DOI: 10.1161/JAHA.114.001540

similar development of subclinical atherosclerosis as their
obese counterparts. This study highlights the importance of
assessing cardiometabolic risk in Mexican-Americans regardless of BMI. Carotid IMT has been found to predict future risk
of myocardial infarction and stroke, and a change in cIMT has
been validated as a vascular marker for the progression of
atherosclerosis.29–31 Subclinical atherosclerosis is prevalent
in this asymptomatic community-recruited cohort and is
paralleled by the high prevalence of participants classiﬁed as
metabolically unhealthy.
Our study is consistent with a large health-screening
cohort study among Asians that demonstrated that metabolically unhealthy obese participants had similar coronary artery
calcium scores as metabolically unhealthy non-obese participants,24 and the authors also suggested that metabolic
health was more important in the development of overt
atherosclerosis than obesity. In a white and black female
cohort, Khan et al similarly demonstrated increased prevalence of subclinical atherosclerosis in metabolically abnormal
overweight/obese women compared with their metabolically
benign counterparts.22 In a Hispanic cohort, data from the
San Antonio Heart Study showed that the risk of incident CVD
(median follow-up of 7.4 years) was increased in metabolically
unhealthy normal weight participants but that there was no
gradation of this risk by BMI.32 In other words, CVD risk did
not depend on BMI among these participants and was related
more to their baseline cardiometabolic risk. On the other
hand, incident CVD had a gradation in risk by BMI among
those who were metabolically healthy but obese, and those
participants who were at the higher end of the obesity
spectrum (ie, morbidly obese) were more likely to develop
incident CVD. The authors suggested that these participants
may have transitioned into a metabolically unhealthy phenotype. Indeed Appleton et al reported that metabolically
healthy obese individuals are at increased risk of incident
Journal of the American Heart Association
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Variable

Parameter Estimate

Standard Error

t Value

P>[t]

0.260

0.029

9.1

<0.0001

Obese (BMI≥30 kg/m )

0.023

0.016

1.46

0.1446

Metabolically unhealthy (>2 cardiometabolic risk factors)

0.033

0.014

2.42

0.0156

Age

0.007

0.001

11.38

<0.0001

Gender

0.047

0.015

3.05

0.0025

Adjusted Means

Standard Error

t Value

P>[t]

1.46

0.1446

2.42

0.0156

3.05

0.0025

Estimated regression coefficients
Intercept
2

Adjusted means and standard error based on multivariable regression model
Obese (BMI≥30 kg/m2)
Obese

0.67

0.01

Not obese

0.65

0.01

Metabolically unhealthy (>2 cardiometabolic risk factors)
Metabolically unhealthy

0.68

0.01

Metabolically healthy

0.64

0.01

Male

0.68

0.01

Female

0.64

0.01

Gender

BMI indicates body mass index.

diabetes mellitus only if they progress to an unhealthy
phenotype.33 Hence stability of metabolic health in the
metabolically healthy obese phenotype appears to be crucial
for the prevention of CV events.
Only 10% of obese individuals in our cohort were classiﬁed
as metabolically healthy compared with the 31.7% prevalence
for the entire US population based on the National Health and
Nutrition Examination Survey (NHANES) data.21 The prevalence of the metabolically unhealthy obese phenotype in our
cohort on the other hand, is more than twice that of the
prevalence reported for the NHANES data (48.1% for the
CCHC versus 20.9% for the NHANES data).21 Also worrisome
is that only 17.8% of our cohort was classiﬁed as metabolically healthy non-obese compared with the much higher
prevalence estimate of 44.3% for the US population.21 These
ﬁndings emphasize not only the obesity disparity among
Mexican-Americans compared with the US population as a
whole but brings to light the ﬁnding that among non-obese
Mexican-Americans, there is already a high prevalence of
clustering of cardiometabolic risk factors. Our ﬁnding that the
metabolically unhealthy phenotype was associated with age,
male gender, and lower education levels is consistent with
that from other large multi-ethnic studies such as The
Atherosclerosis Risk in Communities Study (ARIC) and
NHANES data,21,34 but in addition we demonstrated that
DOI: 10.1161/JAHA.114.001540

abdominal adiposity and less intake of fruits and vegetables
are also associated with being metabolically unhealthy.
The World Health Organization (WHO) deﬁnes obesity as
“abnormal or excessive fat accumulation in adipose tissue, to
the extent that health is impaired.”35 Visceral adipose tissue
is a metabolically active organ secreting hormones, cytokines,
and growth factors (collectively called adipocytokines or
adipokines),36,37 and is known to be associated with insulin
resistance and its related metabolic abnormalities.38 However, in the clinical setting, accurate measurement of adipose
tissue is relatively difﬁcult and surrogate measures of
adiposity are used routinely instead. BMI, one such surrogate
measure of adiposity has proven to be relatively reliable,39
and in 2000, the WHO released an updated deﬁnition of
overweight and obesity based on BMI criteria.40 BMI,
however, cannot distinguish between fat tissue and lean
tissue, is somewhat arbitrary, and has limitations in predicting
risk in certain ethnic groups.41 BMI generally overestimates
adiposity in persons with more lean body mass, such as
athletes, and underestimates excess adiposity in persons with
less lean body mass. Furthermore, the reference tables used
regarding desirable weight-for-height values were based on
the mortality experience of life insurance policies in the
United States and Canada, a mostly white cohort.42,43 Our
ﬁnding that cardiometabolic risk is signiﬁcantly associated
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drawing from clinic populations with mixed ethnicity and
established disease. Although the majority of covariates
evaluated in this study were objectively measured, the use
of questionnaires to assess physical activity and intake of
fruits and vegetables has known disadvantages, particularly
recall bias and measurement error. Nevertheless, the physical
activity and food frequency questionnaires we used in this
study have been validated for this ethnic group.15 Prospective
studies are needed to determine whether targeted modiﬁcation
of cardiometabolic risk rather than focusing solely on weight
loss actually translates to reduced cardiac events. Longitudinal
data currently being collected should eventually provide this
answer. In addition, a larger sample size is needed to conﬁrm
our ﬁndings as some obesity phenotype categories (particularly
the metabolically healthy obese group) had smaller numbers of
observations. On the other hand, the current study has a
number of strengths, one of which is the very homogeneity of
the cohort studied. To fully understand prevalent risk among
Hispanics, the Hispanic population needs to be disaggregated
into subgroups according to national origins and other
characteristics49 as the paradoxical and conﬂicting ﬁndings
related to CV health among Hispanics may reﬂect aggregation
error of outcomes data across widely varied subgroups.50
In summary, a substantial gap still remains, particularly
among ethnic groups, in the detection of asymptomatic
individuals who ultimately develop CVD. In the United States,
the Hispanic population has almost doubled between 1990
and 2007 (9% to 15%),51 and is projected to reach 30% by the
year 2050. Of the Hispanics residing in the United States,
Mexican-Americans represent the largest and ethnically distinct subgroup. Hence, understanding and describing prevalent
disease as well as deﬁning and reducing risk burden in this
minority population are important as the racial/ethnic landscape of the United States continues to change. More
research is needed to identify factors that can prevent or
potentially reverse the clustering of metabolic abnormalities in
all categories of BMI. In our cohort, low cardiometabolic risk
was uncommon, so maintenance of metabolic health in the
Mexican-Americans remains a major challenge. The ﬁndings in
this study are particularly relevant to future public health
planning as interventions to maintain metabolic health may be
more important goal than focusing on weight loss alone.
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with subclinical atherosclerosis regardless of BMI, highlights
the limitation of using BMI alone in Mexican-Americans. We
did quantify waist circumference as a measure of central
adiposity and showed that this was different among the
metabolically healthy or unhealthy phenotypes regardless of
whether they were obese or not, but this was not signiﬁcantly
associated with subclinical atherosclerosis after adjusting for
the other covariates. For future studies, we will look at dual Xray absorptiometry (DXA) scans in order to more accurately
quantitate visceral adiposity.
In this study we chose to use the criterion for metabolic
health as deﬁned for the US population from the NHANES
database.21 To date, there is no standardized deﬁnition of
obesity phenotypes and metabolic health and there are
over 30 different deﬁnitions of metabolic health in the
literature.44 However in one study, 3 deﬁnitions of metabolic health were compared and no signiﬁcant differences
in the relationship of obesity phenotypes to all-cause
mortality were seen regardless of the deﬁnition used.44 We
believe that variation across ﬁndings among different
studies is not unexpected, but the main tenet that
abnormal metabolic health impacts prevalence of CVD to
a greater extent than BMI alone appears to be consistent.
Consensus is needed if we are to move this concept to
health policy and clinical care.
It has been suggested that obesity phenotypes represent
heritable traits,45 but the genetic factors modulated by
environmental factors mediating metabolic health among
obese persons are not yet deﬁned. On the other hand, one
environmental factor that has been studied in these patients
is level of physical activity. Indeed, it has been suggested that
although body fatness and ﬁtness are strong predictors of
CVD, level of ﬁtness largely negates the adverse effects of
body fatness on CV morbidity and mortality.46–48 In our study,
we did not ﬁnd physical activity to be signiﬁcantly associated
with metabolic health regardless of BMI, and this covariate
was not independently associated with subclinical atherosclerosis in a regression analysis after adjusting for other
covariates. This ﬁnding is relevant and will need to be
validated in a larger cohort study, but does suggest that
improving ﬁtness may not be a ﬁrst approach to reducing risk
in Mexican-Americans. On the other hand, meeting recommendations regarding daily intake of fruits and vegetables
was signiﬁcantly different among those who were metabolically healthy or not in our cohort, and this ﬁnding can be
applied when designing public health initiatives to reduce CVD
risk in Mexican-Americans.
There are some factors that may affect our results. This is a
cross-sectional study and cIMT was only evaluated once
without long-term follow-up. However, this is a unique population-based sample of randomly selected, apparently healthy,
Mexican-Americans, thus avoiding bias inherent in studies
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